Operating Lease, Right-of-Use Asset of T2 Biosystems, Inc. from 31 Mar 2019 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
T2 Biosystems, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2024.
  • T2 Biosystems, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2024 was $6,268,000, a 19% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

T2 Biosystems, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $6,268,000 -$1,479,000 -19% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $6,656,000 -$1,432,000 -18% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $7,031,000 -$1,389,000 -16% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 $7,395,000 -$1,346,000 -15% 31 Dec 2023 10-Q 14 Nov 2024 2024 Q3
Q3 2023 $7,747,000 -$1,311,000 -14% 30 Sep 2023 10-Q 15 Nov 2023 2023 Q3
Q2 2023 $8,088,000 -$1,081,000 -12% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $8,420,000 -$1,052,000 -11% 31 Mar 2023 10-Q 22 May 2023 2023 Q1
Q4 2022 $8,741,000 -$1,025,000 -10% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $9,058,000 -$994,000 -9.9% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $9,169,000 -$1,163,000 -11% 30 Jun 2022 10-Q 16 Aug 2022 2022 Q2
Q1 2022 $9,472,000 -$1,134,000 -11% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $9,766,000 -$1,268,000 -11% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 $10,052,000 +$8,323,000 +481% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $10,332,000 +$8,256,000 +398% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $10,606,000 +$7,640,000 +258% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $11,034,000 +$7,674,000 +228% 31 Dec 2020 10-K 23 Mar 2022 2021 FY
Q3 2020 $1,729,000 -$2,011,000 -54% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $2,076,000 -$2,032,000 -49% 30 Jun 2020 10-Q 12 Aug 2020 2020 Q2
Q1 2020 $2,966,000 -$1,497,000 -34% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $3,360,000 31 Dec 2019 10-K 31 Mar 2021 2020 FY
Q3 2019 $3,740,000 30 Sep 2019 10-Q 18 Nov 2019 2019 Q3
Q2 2019 $4,108,000 30 Jun 2019 10-Q 02 Aug 2019 2019 Q2
Q1 2019 $4,463,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.